Emilie Lalonde
Emilie Lalonde
ABMGG Laboratory Fellow, Children's Hospital of Philadelphia and University of Pennsylvania
Verified email at email.chop.edu
TitleCited byYear
What can exome sequencing do for you?
J Majewski, J Schwartzentruber, E Lalonde, A Montpetit, N Jabado
Journal of medical genetics 48 (9), 580-589, 2011
3772011
Spatial genomic heterogeneity within localized, multifocal prostate cancer
PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ...
Nature genetics 47 (7), 736, 2015
2762015
Genomic hallmarks of localized, non-indolent prostate cancer
M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ...
Nature 541 (7637), 359-364, 2017
2122017
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ...
The lancet oncology 15 (13), 1521-1532, 2014
1982014
Unexpected allelic heterogeneity and spectrum of mutations in Fowler syndrome revealed by next‐generation exome sequencing
E Lalonde, S Albrecht, KCH Ha, K Jacob, N Bolduc, C Polychronakos, ...
Human mutation 31 (8), 918-923, 2010
1342010
RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression
E Lalonde, KCH Ha, Z Wang, A Bemmo, CL Kleinman, T Kwan, ...
Genome research 21 (4), 545-554, 2011
1212011
A prostate cancer “nimbosus”: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies
MLK Chua, W Lo, M Pintilie, J Murgic, E Lalonde, V Bhandari, ...
European urology 72 (5), 665-674, 2017
662017
Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease
GI Allen, N Amoroso, C Anghel, V Balagurusamy, CJ Bare, D Beaton, ...
Alzheimer's & Dementia 12 (6), 645-653, 2016
572016
Familial rhabdoid tumour 'avant la lettre'—from pathology review to exome sequencing and back again
L Witkowski, E Lalonde, J Zhang, S Albrecht, N Hamel, L Cavallone, ...
The Journal of pathology 231 (1), 35-43, 2013
542013
An RMND1 Mutation Causes Encephalopathy Associated with Multiple Oxidative Phosphorylation Complex Deficiencies and a Mitochondrial Translation Defect
A Janer, H Antonicka, E Lalonde, T Nishimura, F Sasarman, GK Brown, ...
The American Journal of Human Genetics 91 (4), 737-743, 2012
512012
Mutations in SCARF2 are responsible for Van Den Ende-Gupta syndrome
N Anastasio, T Ben-Omran, A Teebi, KCH Ha, E Lalonde, R Ali, ...
The American Journal of Human Genetics 87 (4), 553-559, 2010
502010
Epigenetic markers of prostate cancer in plasma circulating DNA
R Cortese, A Kwan, E Lalonde, O Bryzgunova, A Bondar, Y Wu, ...
Human molecular genetics 21 (16), 3619-3631, 2012
442012
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines
KCH Ha, E Lalonde, L Li, L Cavallone, R Natrajan, MB Lambros, ...
BMC medical genomics 4 (1), 75, 2011
382011
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair
A Dal Pra, E Lalonde, J Sykes, F Warde, A Ishkanian, A Meng, C Maloff, ...
Clinical Cancer Research 19 (18), 5202-5209, 2013
372013
Translating a prognostic DNA genomic classifier into the clinic: retrospective validation in 563 localized prostate tumors
E Lalonde, R Alkallas, MLK Chua, M Fraser, S Haider, A Meng, J Zheng, ...
European urology 72 (1), 22-31, 2017
302017
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer
A Berlin, E Lalonde, J Sykes, G Zafarana, KC Chu, VR Ramnarine, ...
Oncotarget 5 (22), 11081, 2014
252014
Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient
J Zhang, Y Shi, E Lalonde, L Li, L Cavallone, A Ferenczy, WH Gotlieb, ...
BMC cancer 13 (1), 146, 2013
182013
Mining human prostate cancer datasets: The “camcAPP” Shiny App
MJ Dunning, SL Vowler, E Lalonde, H Ross-Adams, P Boutros, IG Mills, ...
EBioMedicine 17, 5-6, 2017
172017
PRiMeUM: a model for predicting risk of metastasis in uveal melanoma
J Vaquero-Garcia, E Lalonde, KG Ewens, J Ebrahimzadeh, ...
Investigative ophthalmology & visual science 58 (10), 4096-4105, 2017
162017
Germline mutations in the kallikrein 6 region and predisposition for aggressive prostate cancer
L Briollais, H Ozcelik, J Xu, M Kwiatkowski, E Lalonde, DH Sendorek, ...
JNCI: Journal of the National Cancer Institute 109 (4), 2017
102017
The system can't perform the operation now. Try again later.
Articles 1–20